Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05025761Not ApplicableUnknown

Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar

Role: collaborator

NCT04695886Not ApplicableUnknown

Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar

Role: collaborator

NCT01872702Not ApplicableCompleted

Targeted Chemo-elimination (TCE) of Malaria

Role: collaborator

NCT03648411Completed

Drug Resistance Among Asymptomatic Infection

Role: collaborator

All 4 trials loaded